With over two decades of experience in domestic and international patent prosecution, Martin, a senior patent agent, predominantly works with clients in the fields of biochemistry, cell and molecular biology, bioinformatics, medical devices, pharmaceutical chemistry, nutraceuticals, organic chemistry, electrochemistry, chemical engineering, and general mechanical arts. He also holds several patents in the biotechnology area.

In addition to preparing and prosecuting U.S., PCT, and foreign patent applications, Martin provides clients with patent portfolio analysis and IP strategy to ensure clients have and will obtain patent coverage that is relevant to their business. Clients rely heavily on Martin and his expertise with patentability, freedom-to-operate, and infringement analyses, as well as his brainstorming sessions on strategies to avoid potential or existing infringement issues.

Martin has represented a large variety of clients across multiple industries ranging from Fortune 500 companies and publicly traded companies to domestic and foreign universities, small business entities, and individual inventors. He also holds several patents in the biotechnology area. Martin successfully completed advanced training courses in PCT and EPO patent prosecution, and has substantial experience in patent practice in many foreign countries, including Australia, Canada, China, Israel, India, Japan, Russia, and most European countries. Martin is fluent in English and German, and proficient in French.

Before his career in patent prosecution, Martin enjoyed several years of postdoctoral research at The Scripps Research Institute.  Martin was also a project leader in a biotechnology company in San Diego, CA, developing recombinant proteins with tailored substrate specificities.